Development of an integrated sample amplification control for salivary point-of-care pathogen testing
- PMID: 38182338
- PMCID: PMC10860388
- DOI: 10.1016/j.aca.2023.342072
Development of an integrated sample amplification control for salivary point-of-care pathogen testing
Abstract
Background: The COVID-19 pandemic has led to a rise in point-of-care (POC) and home-based tests, but concerns over usability, accuracy, and effectiveness have arisen. The incorporation of internal amplification controls (IACs), essential control for translational POC diagnostics, could mitigate false-negative and false-positive results due to sample matrix interference or inhibition. Although emerging POC nucleic acid amplification tests (NAATs) for detecting SARS-CoV-2 show impressive analytical sensitivity in the lab, the assessment of clinical accuracy with IACs is often overlooked. In some cases, the IACs were run spatially, complicating assay workflow. Therefore, the multiplex assay for pathogen and IAC is needed.
Results: We developed a one-pot duplex reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) assay for saliva samples, a non-invasive and simple collected specimen for POC NAATs. The ORF1ab gene of SARS-CoV-2 was used as a target and a human 18S ribosomal RNA in human saliva was employed as an IAC to ensure clinical reliability of the RT-LAMP assay. The optimized assay could detect SARS-CoV-2 viral particles down to 100 copies/μL of saliva within 30 min without RNA extraction. The duplex RT-LAMP for SARS-CoV-2 and IAC is successfully amplified in the same reaction without cross-reactivity. The valid results were easily visualized in triple-line lateral flow immunoassay, in which two lines (flow control and IAC lines) represent valid negative results and three lines (flow control, IAC, and test line) represent valid positive results. This duplex assay demonstrated a clinical sensitivity of 95%, specificity of 100%, and accuracy of 96% in 30 clinical saliva samples.
Significance: IACs play a crucial role in ensuring user confidence with respect to the accuracy and reliability of at-home and POC molecular diagnostics. We demonstrated the multiplex capability of SARS-COV-2 and human18S ribosomal RNA RT-LAMP without complicating assay design. This generic platform can be extended in a similar manner to include human18S ribosomal RNA IACs into different clinical sample matrices.
Keywords: Diagnostic; Internal amplification control; Lateral flow immunoassay; Reverse transcription loop-mediated isothermal amplification; SARS-CoV-2; Saliva.
Copyright © 2023 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest Jacqueline C. Linnes is co-founder of EverTrue LLC, a diagnostics company developing paper-based POC NAATs, and co-founder of OmniVis Inc. NAAT company developing POC diagnostics. Navaporn Sritong, Winston Wei Ngo, and Karin F. K. Ejendal have declared that they have no competing interests.
Update of
-
Development of an Integrated Sample Amplification Control for Salivary Point-of-Care Pathogen Testing.medRxiv [Preprint]. 2023 Oct 3:2023.10.03.23296477. doi: 10.1101/2023.10.03.23296477. medRxiv. 2023. Update in: Anal Chim Acta. 2024 Jan 25;1287:342072. doi: 10.1016/j.aca.2023.342072. PMID: 37873363 Free PMC article. Updated. Preprint.
Similar articles
-
Development of an Integrated Sample Amplification Control for Salivary Point-of-Care Pathogen Testing.medRxiv [Preprint]. 2023 Oct 3:2023.10.03.23296477. doi: 10.1101/2023.10.03.23296477. medRxiv. 2023. Update in: Anal Chim Acta. 2024 Jan 25;1287:342072. doi: 10.1016/j.aca.2023.342072. PMID: 37873363 Free PMC article. Updated. Preprint.
-
PD-LAMP smartphone detection of SARS-CoV-2 on chip.Anal Chim Acta. 2022 Apr 22;1203:339702. doi: 10.1016/j.aca.2022.339702. Epub 2022 Mar 9. Anal Chim Acta. 2022. PMID: 35361434 Free PMC article.
-
Rapid isothermal amplification and portable detection system for SARS-CoV-2.Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):22727-22735. doi: 10.1073/pnas.2014739117. Epub 2020 Aug 31. Proc Natl Acad Sci U S A. 2020. PMID: 32868442 Free PMC article.
-
LAMP Diagnostics at the Point-of-Care: Emerging Trends and Perspectives for the Developer Community.Expert Rev Mol Diagn. 2021 Jan;21(1):43-61. doi: 10.1080/14737159.2021.1873769. Epub 2021 Jan 27. Expert Rev Mol Diagn. 2021. PMID: 33474990 Review.
-
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3. Cochrane Database Syst Rev. 2022. PMID: 35866452 Free PMC article. Review.
References
-
- Figueroa C, Johnson C, Ford N, Sands A, Dalal S, Meurant R, Prat I, Hatzold K, Urassa W, Baggaley R, Reliability of HIV rapid diagnostic tests for self-testing compared with testing by health-care workers: a systematic review and meta-analysis, Lancet HIV. 5 (2018) e277–e290. 10.1016/S2352-3018(18)30044-4. - DOI - PMC - PubMed
-
- Class II Special Controls Guideline: In Vitro Diagnostic Devices for Bacillus spp. Detection, (n.d.).
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous